Analyst Reacts to FDA Comments: Medical and Recreational Cannabis Could Have Separate Regulations

Loading... Loading...

FDA Commissioner Robert from California Thursday testimony sets off new conversation about THE future of cannabis In THE United States in particular concerning It is medical And recreational rankings.

In A recent note, senior analyst Paul Zuanique Since Zuanique & Associates strong points THE critical points Since from California appearance Before THE House

Committee on Monitoring And Responsibility.

from California affirmation that "there East No reason For THE DEA has delay" THE reprogramming of cannabis grasped securities, Again Zuanique urges stakeholders has look Deeper In THE nuances of from California declarations, particularly her knowledge on THE bifurcation between medical And recreational cannabis.

Medical Against. Recreational Cannabis: A Imminent Decision

THE FDA of the commissioner differentiation between medical And recreational cannabis suggests A imminent federal pivot towards reprogramming only medical cannabis This year.

"Medical cannabis East A thing When used For proven medical trails, but SO if he East used For recreational purposes there are No medical benefits In that case, And he do not autumn In THE typical FDA skill of regulations," California explained.

THE report suggests that reprogramming could only apply has medical cannabis, with recreational to use remaining below State control For now.

Regulatory Lanes And THE Role Of Congress

California underlines THE complexity of cannabis regulation And THE FDA role. "This East A very complicated subject."

With on "30 different shapes of cannabis" And State regulations predominant, California voiced A preference For Congress action has establish clear federal guidelines, especially For recreational cannabis.

Zuanique see This as A indication that, until Congress actions, THE Status what, Or States individually decide on THE legality of recreational cannabis, East likely has continue.

Cannabis reprogramming And CBD will be the subjects of great interest has THE coming soon: Benzinga Cannabis Capital Conference on April 16-17" Florida. Join We For This two days event At Diplomat Beach Station for A chance has meet entrepreneurs, both big And little, has network, learn And grow up. Marc your calendars — This conference East THE go to event of THE year For THE cannabis world.

CBD Regulatory Path Waits Congress Action

THE FDA maintains that CBD do not to qualify as A dietetic extra charge due has concerns on pupil liver enzymes, to differ has Congress has establish A clear regulatory frame.

Despite many citizen petitions For dietetic extra charge classification, THE agency gives priority A harm reduction approach, on hold legislative advice.

THE report note HOUR. 1629 look for has legalize derived from hemp CBD In dietetic supplements, quota on meeting specific criteria, Again THE FDA current position forbidden CBD some products Since be commercialized as tel.

Consequences For THE Industry And Investors

THE distinction do by California between Me...